Cargando…
GATA3 Inhibits Lysyl Oxidase Mediated Metastases of Human Basal Triple-Negative Breast Cancer Cells
Discovery of mechanisms that impede the aggressive and metastatic phenotype of human basal triple-negative type breast cancers (BTNBC) could provide novel targets for therapy for this form of breast cancer that has a relatively poor prognosis. Previous studies have demonstrated that the expression o...
Autores principales: | Chu, Isabel M., Michalowski, Aleksandra M., Hoenerhoff, Mark, Szauter, Kornelia M., Luger, Dror, Sato, Misako, Flanders, Kathy, Oshima, Akira, Csiszar, Katalin, Green, Jeffrey E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235255/ https://www.ncbi.nlm.nih.gov/pubmed/21892208 http://dx.doi.org/10.1038/onc.2011.382 |
Ejemplares similares
-
Lysyl Oxidase (LOX): Functional Contributions to Signaling Pathways
por: Laczko, Rozalia, et al.
Publicado: (2020) -
The Interactome of Cancer-Related Lysyl Oxidase and Lysyl Oxidase-Like Proteins
por: Vallet, Sylvain D., et al.
Publicado: (2020) -
Multifunctional Lysyl Oxidases
por: Trackman, Philip C.
Publicado: (2023) -
Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas
por: Moreno-Bueno, Gema, et al.
Publicado: (2011) -
Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases
por: Rachman-Tzemah, Chen, et al.
Publicado: (2017)